| Fonds | 2026/Q1 | 2025/Q4 | 2025/Q3 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | |
| 176.528.262 $ | -4.311.411 $ | +7,7 % | 210.498.157 $ | +50.032.741 $ | +249,3 % | 80.046.228 $ | +39.119.505 $ | +95,8 % | |
| GordonMD Global Investments LP | 36.632.779 $ | -4.650.310 $ | -11,3 % | 41.283.089 $ | |||||
| GILEAD SCIENCES, INC. | 35.608.407 $ | -3.177.112 $ | -8,2 % | 38.785.519 $ | +14.028.805 $ | +56,7 % | 24.756.714 $ | +12.089.529 $ | +95,4 % |
| Bain Capital Life Sciences Investors, LLC | 26.839.300 $ | -2.394.700 $ | -8,2 % | 29.234.000 $ | +9.023.780 $ | +44,6 % | 20.210.220 $ | +9.869.324 $ | +95,4 % |
| Vida Ventures Advisors, LLC | 27.143.544 $ | +13.255.097 $ | +95,4 % | ||||||
| DEERFIELD MANAGEMENT COMPANY, L.P. | 17.260.000 $ | -1.540.000 $ | -8,2 % | 18.800.000 $ | |||||
| AIGH Capital Management LLC | 17.260.000 $ | +3.160.000 $ | +22,4 % | 14.100.000 $ | |||||
| VANGUARD GROUP INC | 16.743.815 $ | +8.808.065 $ | +111,0 % | 7.935.750 $ | +3.905.555 $ | +96,9 % | |||
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 15.666.660 $ | ||||||||
| BALYASNY ASSET MANAGEMENT L.P. | 9.711.520 $ | +491.351 $ | +5,3 % | 9.220.169 $ | |||||
| MORGAN STANLEY | 8.434.004 $ | -989.449 $ | -10,5 % | 9.423.453 $ | +8.378.235 $ | +801,6 % | |||
| Insight Holdings Group, LLC | 8.535.536 $ | -761.572 $ | -8,2 % | 9.297.108 $ | +3.362.784 $ | +56,7 % | |||
| MILLENNIUM MANAGEMENT LLC | 8.677.534 $ | +3.099.865 $ | +55,6 % | ||||||
| Woodline Partners LP | 7.944.344 $ | +6.431.072 $ | +425,0 % | ||||||
| BlackRock, Inc. | 7.569.182 $ | +2.450.516 $ | +47,9 % | ||||||
| 176.528.262 $ | -4.311.411 $ | +7,7 % | 210.498.157 $ | +50.032.741 $ | +249,3 % | 80.046.228 $ | +39.119.505 $ | +95,8 % | |